Our data also identify CCL14 and CCL23 as warranting further investigation, with marginally significant (uncorrected) trends towards transmission distortion found in RR-MS and SP-MS patients for CCL14 -649T>A, and in males for CCL23 -289A>C. The gene discussed is CCL23; the disease is myeloid sarcoma.